Carbamazepine versus lithium in mania: a double-blind study. 1987

B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon

Thirty-four manic patients were randomly assigned to treatment with carbamazepine or lithium. Clinical response was rated over 4 weeks. Twenty-eight patients, 14 in each group, completed the full protocol. Serum levels for both drugs were within the accepted therapeutic range. The overall response to treatment was not significantly different between the two groups. Comparison of individual Clinical Global Impressions, Brief Psychiatric Rating Scale, and Beigel-Murphy Manic State Rating Scale change scores showed a more consistent level of improvement across patients in the lithium-treated group compared to a minority of good responders in the carbamazepine-treated group. The findings suggest that carbamazepine has antimanic potential in specific bipolar patients whose clinical characteristics remain to be clearly defined.

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002220 Carbamazepine A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. Amizepine,Carbamazepine Acetate,Carbamazepine Anhydrous,Carbamazepine Dihydrate,Carbamazepine Hydrochloride,Carbamazepine L-Tartrate (4:1),Carbamazepine Phosphate,Carbamazepine Sulfate (2:1),Carbazepin,Epitol,Finlepsin,Neurotol,Tegretol
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females

Related Publications

B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
January 2008, International journal of psychiatry in clinical practice,
B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
October 1969, Archives of general psychiatry,
B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
July 1980, Psychopharmacology bulletin,
B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
December 2009, Bipolar disorders,
B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
April 1986, Indian journal of psychiatry,
B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
January 2008, Journal of affective disorders,
B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
February 1984, Archives of general psychiatry,
B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
May 1983, Archives of general psychiatry,
B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
March 2000, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists,
B Lerer, and N Moore, and E Meyendorff, and S R Cho, and S Gershon
November 1999, International clinical psychopharmacology,
Copied contents to your clipboard!